Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept with Pranoprofen or Omega-3 in AMD
NCT03355638Phase 4Completed
- Sponsor
- University of Brescia
- Start
- Jan 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of pranoprofen, omega-3 fatty acid in Age-related macular degeneration (AMD), sponsored by University of Brescia. Started Jan 2016; status: completed.
02
Drugs
pranoprofenomega-3 fatty acid
03
Conditions
Age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT03355638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355638.